Syros

$8.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+2.90%) Today

$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Syros and other stocks, options, and ETFs commission-free!

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA. The listed name for SYRS is Syros Pharmaceuticals, Inc. Common Stock.

CEO

Nancy A. Simonian

Employees

Headquarters

Cambridge, Massachusetts

Founded

2011

Market Cap

373.36M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

404.20K

High Today

$8.29

Low Today

$7.92

Open Price

$8.04

Volume

191.63K

52 Week High

$14.69

52 Week Low

$4.26

Collections

Analyst Ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

SYRS Earnings

-$0.57

-$0.38

-$0.19

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4